SCIESCOPUSQ2
Cardiovascular Therapeutics
WILEY, China
Cardiovascular Therapeutics is an academic journal published by WILEY (China). Identifiers: ISSN 1755-5914, eISSN 1755-5922. Indexed in SCIE, SCOPUS. Metrics: JIF 3.4, CiteScore 5.8, SJR 0.831, SNIP 0.94. Subject areas: CARDIAC & CARDIOVASCULAR SYSTEM, PHARMACOLOGY & PHARMACY. tlooto lists 1,101 papers from this journal.
CiteScore
5.80
Scopus citation metric
SJR
0.831
SCImago rank
SNIP
0.94
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1755-5914
- eISSN
- 1755-5922
- Abbreviation
- CARDIOVASC THER
- Publisher
- WILEY
- Country
- China
Web of Science categories
SCIECARDIAC & CARDIOVASCULAR SYSTEM, PHARMACOLOGY & PHARMACY
Scopus ASJC categories
2705 Cardiology and Cardiovascular Medicine2736 Pharmacology (medical)3004 Pharmacology
Keywords
Cardiac & Cardiovascular System | Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Hypermetabolism and Lipid Alterations Postburn: A Cardiovascular Perspective
2026
- Epigenetic Regulation of ITGB7 Promotes Coronary Heart Disease via Immune and Metabolic Pathways: A Multimodal Mendelian Randomization Study
2026
- IL6/IL10/TLR4 Govern Immunogenic Cell Death in Aortic Dissection
2026
- Oxycodone: A Pain‐Relieving Agent With Cardioprotective Properties Against Myocardial Ischemia–Reperfusion Injury
2026 · 2 citations
- Comparative Outcomes of Fractional Flow Reserve and Intravascular Ultrasound Guidance for Percutaneous Coronary Intervention in Intermediate Lesions: A Systematic Review and Meta‐Analysis
2026
Most cited papers
- Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
2012 · 650 citations
- Hypolipidemic, Antioxidant and Antiinflammatory Activities of Microalgae Spirulina
2010 · 457 citations
- PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1): A KEY FACTOR LINKING FIBRINOLYSIS AND AGE-RELATED SUBCLINICAL AND CLINICAL CONDITIONS
2010 · 409 citations
- Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
2019 · 381 citations
- Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist
2009 · 354 citations